About Advamedic

Added Value Medicines Consultancy was founded by Wil Toenders, who has long and broad experience in assessing the value of medicines and the best way to obtain reimbursement in the Netherlands. This applies to medicines used both within and outside of hospitals, and in all areas of therapy.

Wil has many years of experience in the field of pharmacotherapy, drug and reimbursement policy, health insurance, cost-effectiveness and pricing. This is mainly based on his former position as head of drug assessment at the National Health Care Institute. It has resulted in extensive knowledge and practical expertise from within institutions about how reimbursement processes work. He also knows the jurisprudence that determines current reimbursement policy, and which arguments to use that can make a difference. He has a broad network including government officials, healthcare professionals and health insurers. Solutions are devised in an ethical and sustainable way with a view to maintaining good relationships with all stakeholders in the long term.

He subsequently gained more than 13 years of experience as an independent consultant in drug reimbursement. In addition to government and health insurers, his clients have included many pharmaceutical companies, ranging from small biotech companies with only one drug or just a pipeline to large companies with various new market introductions every year.

The range of services offered by ADVAMEDIC is broad. It varies from participation in advisory boards in the early development phase, from providing realistic analyses of the feasibility of reimbursement to writing complete reimbursement files and guiding the entire reimbursement process. See further under ‘Services’.

Wil Toenders works closely together in a network of other experts in areas such as registration, pharmacotherapy, budget impact and pharmacoeconomics. Internationally, the collaboration is aimed at submitting joint reimbursement files in the context of the BeNeLuxA initiative.